biosynthesis

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has invested an additional $2.5 million in a private biotechnology company Hyasynth Biologicals Inc. It’s the second tranche of financing under the $10 million debenture purchase deal between Organigram Inc. – a subsidiary of...